Solvonis Therapeutics (LSE:SVNS) Days Payable: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Solvonis Therapeutics Days Payable?

Solvonis Therapeutics LSE:SVNS -2.30% Days Payable is 0.00 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 2,992 Industrial Products companies, Solvonis Therapeutics ranks worse than 33422.43% on this metric.

Solvonis Therapeutics's average Accounts Payable for the six months ended in Dec. 2025 was £0.98 Mil. Solvonis Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2025 was £0.00 Mil.

The historical rank and industry rank for Solvonis Therapeutics's Days Payable or its related term are showing as below:

During the past 8 years, Solvonis Therapeutics's highest Days Payable was 3716.92. The lowest was 190.82. And the median was 1039.46.

LSE:SVNS's Days Payable is not ranked *
in the Industrial Products industry.
Industry Median: 78.045
* Ranked among companies with meaningful Days Payable only.

Solvonis Therapeutics's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Solvonis Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for Solvonis Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solvonis Therapeutics Days Payable Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 3,716.92 456.25 190.82 0.00 0.00

Solvonis Therapeutics Semi-Annual Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.19 0.00 0.00 0.00 0.00

LSE:SVNS vs GEV, ETN, PH: Days Payable Comparison

For the Specialty Industrial Machinery subindustry, Solvonis Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solvonis Therapeutics Days Payable vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Solvonis Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Solvonis Therapeutics's Days Payable falls into.


Solvonis Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Solvonis Therapeutics's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.083 + 0.406) / 2 ) / 0*365
=0.2445 / 0*365
=N/A

Solvonis Therapeutics's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (1.551 + 0.406) / 2 ) / 0*365 / 2
=0.9785 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Solvonis Therapeutics (LSE:SVNS) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Solvonis Therapeutics and its competitors. Over the past decade, Solvonis Therapeutics' Days Payable has ranged from 190.82 to 3,716.92. According to the industry distribution chart, Solvonis Therapeutics ranks #999999 out of 2992 companies in the Industrial Products industry.
Is Solvonis Therapeutics' Days Payable too high?
Solvonis Therapeutics' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 190.82 to a high of 3,716.92. Based on the distribution chart, Solvonis Therapeutics ranks #999999 out of 2992 companies in the Industrial Products industry, which is in the bottom quartile relative to peers.
How does Solvonis Therapeutics' Days Payable compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Solvonis Therapeutics ranks #999999 out of 2992 companies for Days Payable. This places Solvonis Therapeutics in the lower half of its industry. The industry median Days Payable is 78.05. Historically, Solvonis Therapeutics' own Days Payable has ranged from 190.82 to 3,716.92 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Industrial Products company?
The median Days Payable among Industrial Products companies is 78.05, based on 2,992 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Solvonis Therapeutics and its competitors. For the Industrial Products industry, the median Days Payable is 78.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solvonis Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solvonis Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Solvonis Therapeutics (LSE:SVNS) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.00 — trading 91.5% below its estimated fair value. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Solvonis Therapeutics (LSE:SVNS), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solvonis Therapeutics Business Description

Other Exchanges J4I:Germany
Address Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatry. The products in company's pipeline include SVN-001, SVN-002, SVN-015. SVN-114, and others.